Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/9/2025

Trazodone Safety Concerns and Alternatives for Insomnia Management

Critical Safety Concerns

  • The American College of Cardiology recommends caution when prescribing medications that may interact with amiodarone, such as trazodone, due to the risk of elevated trazodone blood levels 2
  • The patient is already taking three serotonergic medications: sertraline, mirtazapine, and quetiapine, which increases the risk of serotonin syndrome when combined with trazodone 3, 4
  • The combination of quetiapine, mirtazapine, and trazodone would create additive sedative effects, particularly dangerous in elderly patients 4, 1

Evidence Against Trazodone for Insomnia

  • The American Academy of Sleep Medicine explicitly recommends against using trazodone for sleep onset or sleep maintenance insomnia in adults, giving it a "WEAK" recommendation against use 1
  • Clinical trials of trazodone 50 mg showed only modest improvements in sleep parameters with no improvement in subjective sleep quality 1
  • Cognitive Behavioral Therapy for Insomnia (CBT-I) should be the initial treatment for chronic insomnia, including components of cognitive therapy, stimulus control therapy, and sleep restriction therapy 1
  • FDA-approved hypnotics, such as zolpidem, eszopiclone, zaleplon, ramelteon, suvorexant, and doxepin, are preferred over trazodone for sleep onset and maintenance 1

Critical Pitfalls to Avoid

  • Any new symptom in elderly patients should be considered a possible adverse drug reaction before adding another medication 4
  • The patient's current medications, including quetiapine, sertraline, and buspirone, may be causing or worsening insomnia, rather than requiring additional treatment 4
  • Adding trazodone would increase the risk of drug-drug interactions from 10.9% to potentially 80.8% 4
  • More than 80% of serious adverse drug reactions are Type A (dose-dependent and potentially avoidable) 4
  • The American Academy of Sleep Medicine recommends never combining two sedating antidepressants, such as mirtazapine and trazodone 1